Astra sues FDA over generic versions of SEROQUEL
Drugs giant AstraZeneca has filed a lawsuit against US regulators to overturn last week's denial of petitions with regard to generic versions of its SEROQUEL and SEROQUEL XR tablets.
Drugs giant AstraZeneca has filed a lawsuit against US regulators to overturn last week's denial of petitions with regard to generic versions of its SEROQUEL and SEROQUEL XR tablets.
The tablets, also know as 'quetiapine fumarate', are an antispsychotic drug used in the treatment of schizophrenia, bipolar disorder and depression.
On March 7th, Astra filed a 'citizens petition' to raise issues regarding labelling requirements for generic copies of "innovative medicines" as well as data exclusivity rights. This was denied by the Food and Drug Administration (FDA).
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The company is attempting to delay the realise onto the market of the generics.
"AstraZeneca seeks an injunction barring the FDA from granting final marketing approval of generic quetiapine until December 2nd 2012 when regulatory exclusivity expires on important clinical trial data, or, alternatively, at least until a federal court has a meaningful opportunity to review imminent FDA action regarding the pending generic marketing applications," the firm said on Tuesday morning.
"AstraZeneca will vigorously defend its legal rights."
BC
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Council tax payment system to be shaken up – what do changes mean for you?
The government plans to make council tax debt collection less aggressive and split bills over 12 months by default
-
European stocks are back in business – can it last?
European stocks enjoy a strong start to the year, but the rally is proving uneven as France struggles to keep up